Halozyme Therapeutics, Inc. revenue breakdown overview

Halozyme Therapeutics, Inc. revenue for the last year amounted to 829.25 M USD, the most of which — 829.25 M USD — came from its highest performing source at the moment, Enzymes and Devices, the year earlier bringing 660.12 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Halozyme Therapeutics, Inc. 587.20 M USD, and the year before that — 437.99 M USD.